AMGN compared with PASG: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

PASGPassage BIO, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

PASGPassage BIO, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AMGN

4 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.7%▲+3.73%×1.00

Q2 FY26±4.1%▲+4.57%×1.12

Q1 FY26±3.9%▼−4.75%×1.23

Feb 4 '26±3.7%▲+8.15%×2.22

PASG

No earnings history for PASG.

= impliedAMGN realized, solidPASG realized, hatchedOne scale, both sides: full bar = 9%× = |realized| ÷ impliedSource: market data

AMGNAmgen Inc

460.55▲+0.06%· post 460.42

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

PASGPassage BIO, Inc.

3.90▲+12.72%· post 3.94

ClosedNov 6 '26

Mkt cap$12.8MRevenue$99,000Q3 FY24Revenue—

Compare

ClosedNov 6 '26

AMGNAmgen Inc

PASGPassage BIO, Inc.

460.55▲+0.06%post 460.42

Price

3.90▲+12.72%post 3.94

$249.0B

Mkt cap

$12.8M

Q3 FY26$10.4B

Revenue

$99,000Q3 FY24

FY25$36.8B

Revenue

—

AMGN460.55▲+0.06%vsPASG3.90▲+12.72%ClosedNov 6 '26